Active Litigation
Kratom Lawsuit Facts
TorHoerman Law is investigating claims for the Kratom Lawsuit.
Active Litigation
TorHoerman Law is investigating claims for the Kratom Lawsuit.
A kratom kidney damage lawsuit may involve acute kidney injury, rhabdomyolysis, or kidney failure allegedly associated with kratom products.
Published cases describe severely impaired kidney function requiring emergency dialysis, while other patients recovered without dialysis.
Kratom products may also contain harmful contaminants, and the FDA has identified lead and nickel in tested products at levels that raise concerns about kidney injury from prolonged exposure.
TorHoerman Law is investigating potential claims involving serious renal injuries allegedly associated with kratom products, inadequate warnings, or contamination.

The medical literature describes several different circumstances in which kidney problems occurred after kratom consumption.
Some patients developed muscle breakdown after severe intoxication, releasing myoglobin into the bloodstream that can damage kidney tubules.
Others experienced kidney injury alongside dehydration, liver damage, gastrointestinal disturbances, or other organ dysfunction.
These reports do not establish that kratom directly damaged the kidneys in every case, and the frequency of kidney injury among kratom users remains uncertain.
Kidney function markers, urine findings, symptoms, and the course of treatment help distinguish different forms of renal injury.
Our attorneys are reviewing potential claims involving acute kidney failure, kidney damage requiring dialysis, and other serious renal complications following kratom use.
Those claims fall within our broader kratom lawsuit investigation.
Call TorHoerman Law today for a free consultation, or use the chat feature on this page to discuss a potential kratom kidney injury claim.
Kratom use has been associated with acute kidney injury in published medical case reports, but the evidence is not sufficient to determine how often kratom independently causes kidney damage.
The available reports involve different products, patterns of use, underlying medical conditions, and sometimes additional medications or serious illnesses, so the potential health risks cannot be attributed to kratom alone.
A 2025 review of published human cases identified kidney complications among reported adverse events but also described limitations in toxicology testing and documentation of other possible causes.
An acute kidney injury (AKI) occurs when renal function declines over hours or days, reducing the kidneys’ ability to remove waste and regulate fluids and electrolytes.
The kidneys filter waste from the blood and regulate fluid balance and potassium homeostasis, the process of maintaining potassium at levels needed for normal muscle and heart function.
AKI differs from chronic kidney disease, which involves persistent kidney abnormalities over time.
Severe AKI may require dialysis, although dialysis during an acute illness does not necessarily mean a person will need it permanently.
Renal problems documented in connection with kratom exposure include:
These are different medical conditions and findings, not interchangeable diagnoses.
There is no single established mechanism for every kidney injury reported after kratom consumption.
Some pathways are well understood as causes of AKI generally, even when a direct causal connection to a particular kratom product remains uncertain.
Rhabdomyolysis occurs when damaged skeletal muscles break down and release substances, including myoglobin, into the bloodstream.
In severe cases, these substances can injure kidney tubules and contribute to acute tubular necrosis.
The resulting kidney dysfunction may be accompanied by high potassium, which can disrupt normal heart rhythms, as well as other electrolyte disturbances and reduced urine production.
Rhabdomyolysis can occur after seizures, prolonged immobility, major muscle injury, or severe intoxication, so a person’s entire medical history and the circumstances of the illness are relevant.
Signs and findings associated with rhabdomyolysis-related kidney injury may include:
A 2021 case report involving a reported kratom overdose documented severe rhabdomyolysis, acute tubular necrosis, and kidney injury requiring emergency hemodialysis.
The case supports a possible route by which complications of severe kratom toxicity can produce kidney injury, but it cannot establish the cause of every rhabdomyolysis case involving kratom.
Severe vomiting, diarrhea, reduced fluid intake, or low blood pressure can reduce blood flow to the kidneys and contribute to AKI.
Published kratom-related cases have described gastrointestinal disturbances and dehydration, but those findings do not prove the kidneys were directly injured by kratom alkaloids.
Kidney injury may also occur alongside liver toxicity or failure affecting several organ systems.
The NIH LiverTox reference on kratom describes rare liver injury beginning within one to eight weeks of regular use, sometimes accompanied by acute kidney failure.
That time frame concerns liver injury, not an established onset period for kratom-related kidney damage.
This makes it important to distinguish direct toxicity from an indirect injury caused by muscle breakdown, reduced kidney perfusion, or a combination of medical problems.
Contamination represents a separate potential source of kidney harm.
The FDA tested 30 kratom products for heavy metals and found lead and nickel concentrations that exceeded its referenced safe oral daily drug-intake exposure levels.
The agency warned that chronic users of contaminated products may face heavy-metal poisoning, including potential kidney and nervous system damage.
Unlike acute kidney injury occurring during an overdose or severe illness, kidney harm from certain metal contaminants may develop through repeated exposure over time.
The FDA’s findings do not mean every kratom product contains unsafe amounts of lead or nickel, or that a particular person’s kidney injury resulted from contamination.
The product’s composition, duration of exposure, and medical findings would need to support that conclusion; FDA testing alone does not identify the cause of an individual patient’s kidney issues.
Individual clinical reports provide details about serious kidney injuries occurring after kratom use, but they cannot determine population-wide risk or establish that kratom was the sole cause in every patient.
A 2021 case report described a 45-year-old woman who developed severe muscle breakdown after a reported kratom overdose.
She also experienced compartment syndrome, acute kidney injury from tubular necrosis, liver dysfunction, and major cardiac complications.
Her potassium level reached 7.6 mmol/L during hospitalization, a dangerously elevated result that can interfere with normal heart function.
She required emergency hemodialysis and extensive hospital treatment, after which the authors reported improvement in renal and liver function.
This case documents a serious acute kidney injury requiring dialysis; it should not be described as proof that the patient developed permanent dialysis dependence.
A separate 2021 case published in ACG Case Reports Journal involved a 37-year-old woman who had taken a kratom-containing herbal supplement for about one year.
She presented with abdominal pain, vomiting, and diarrhea, and her initial serum creatinine was 7.8 mg/dL.
Her condition involved severe liver and kidney injury and intestinal inflammation, with urinary findings suggesting acute tubular necrosis.
She required renal replacement therapy and later underwent a liver transplant because of severe liver failure.
At the time of publication, she had not regained kidney function and remained on dialysis.
The authors considered kratom-associated toxicity a likely contributor but described a complicated illness involving multiple organ systems and another prescribed medication.
The case therefore illustrates the possibility of persistent renal failure, not a predictable outcome from kratom use alone.
A 2022 American Society of Nephrology conference abstract described a 28-year-old man who developed severe AKI after increasing his daily kratom use.
He presented with vomiting, decreased urine output, and evidence of dehydration, and he also had diabetes and was taking other medications.
His serum creatinine rose to 13 mg/dL, and a kidney biopsy showed acute tubular necrosis.
His kidney function gradually improved without dialysis.
This report offers tissue-based evidence of the type of kidney injury, while the contributors to that injury remained uncertain.
These cases show why the clinical course, accompanying medical conditions, and available test results are essential when assessing a suspected kratom-related kidney injury.
Kidney injury does not always cause obvious symptoms at first.
Some patients learn that they have impaired kidney function only after blood or urine testing during treatment for another illness.
Other patients develop changes in urination, fluid retention, weakness, or symptoms related to the underlying cause of the injury.
Possible signs of acute kidney injury include:
Dark urine may reflect muscle breakdown, dehydration, blood in the urine, or liver-related symptoms, so its appearance alone does not identify the cause.
Jaundice and itching may suggest a separate liver injury, particularly when liver enzymes or bilirubin are elevated.
Similarly, bright yellow urine by itself is not evidence of kratom-related kidney damage.
Possible kidney failure signs include substantially reduced urine output, severe weakness, difficulty breathing, confusion, or rapidly worsening swelling, all of which warrant urgent medical evaluation.
A person with severe muscle pain and dark urine may also need emergency assessment for rhabdomyolysis.
High potassium can occur during kidney failure and may cause weakness or abnormal heart rhythms, sometimes without prominent warning symptoms.
When consulting healthcare providers about these symptoms, patients should identify recent kratom products, other medications, and possible substance exposures because they can affect the assessment of kidney injury.
There is no single blood test that proves kratom caused a patient’s kidney injury.
Healthcare providers first determine whether kidney function has declined, assess the severity of the injury, and investigate possible contributors, including medications and other herbal supplements.
Tests commonly used to assess suspected AKI include:
Estimated glomerular filtration rate (eGFR) may be less reliable during a rapidly changing acute injury because commonly used estimates assume relatively stable creatinine levels.
Clinicians may compare current laboratory results with earlier measurements to determine whether kidney function declined suddenly or was already impaired.
The National Kidney Foundation’s guidance on acute kidney injury emphasizes identifying the underlying cause because treatment and recovery depend on it.
Dehydration, infection, diabetes, existing kidney disease, prescription medications, other herbal supplements, and muscle injury can all contribute to abnormal kidney findings.
A reported history of kratom consumption establishes exposure, not necessarily causation.
Likewise, a kidney biopsy can confirm acute tubular necrosis without proving which exposure or illness produced the damage.
If heavy-metal contamination is suspected, the relevant question is whether the specific product contained a harmful contaminant and whether the patient’s medical findings are consistent with that exposure.
A careful timeline of kratom use, physical symptoms, laboratory results, and other illnesses can help medical professionals evaluate these possibilities.
Treatment depends on the type of kidney injury, its severity, and other conditions affecting the patient.
Healthcare professionals may advise stopping a suspected contributing product while treating dehydration, muscle breakdown, low blood pressure, electrolyte disturbances, or other causes.
Hospital treatment may include:
Dialysis may be necessary for severe hyperkalemia, fluid overload, acidosis, or other complications that cannot be adequately managed without kidney replacement therapy.
The decision is based on the patient’s overall condition, not an isolated creatinine number.
People who have become physically dependent on kratom may also experience withdrawal symptoms after stopping it, which healthcare providers can address separately from the kidney injury.
Yes, some patients recover enough kidney function to stop dialysis after acute kidney injury.
The 2021 rhabdomyolysis case and 2022 biopsy-confirmed case demonstrate that renal improvement can occur even after very severe illness.
Other patients develop lasting impairment, as described in the separate 2021 multiorgan dysfunction case.
An episode of AKI can also increase the risk of later chronic kidney disease, even when kidney function initially improves.
The National Kidney Foundation recommends monitoring kidney health after AKI, with follow-up testing ideally within three months of treatment to assess recovery and the potential risks of persistent dysfunction.
This typically involves checking serum creatinine and urine findings, alongside blood pressure and other measures of renal health as appropriate.
No published kratom-specific research establishes a reliable percentage of patients who will recover completely from severe kidney injury.
Our attorneys are reviewing potential claims involving acute kidney failure, dialysis, rhabdomyolysis-associated renal injuries, and possible contamination of kratom products with harmful substances.
The relevant medical questions include what kidney condition was diagnosed, whether it arose during an overdose or another illness, what product was used, and whether other causes were identified.
Medical reports documenting an association between kratom consumption and kidney injury do not automatically establish that a manufacturer or retailer was legally responsible.
More general information about potential defendants, eligibility, evidence, filing deadlines, and compensation is available through our kratom lawsuit investigation.
Call TorHoerman Law today or contact our firm for a free consultation. You can also use the chat feature on this page.
Published case reports describe acute kidney failure after kratom use, including injuries severe enough to require dialysis.
However, the cases often involve rhabdomyolysis, dehydration, liver disease, medications, or other contributing factors.
The available research does not establish the frequency of kidney failure caused directly by kratom.
Rhabdomyolysis is the breakdown of skeletal muscle, which can release myoglobin and other substances that damage kidney tubules.
A published kratom overdose case involved rhabdomyolysis, acute tubular necrosis, severe hyperkalemia, and emergency dialysis.
The presence of rhabdomyolysis requires investigation of possible causes, including seizures, immobility, other drugs, and severe illness.
A 2022 case report described suspected kratom-induced hyperkalemia in a 61-year-old man whose serum creatinine and other kidney-function findings were normal.
His blood potassium returned to normal after he stopped using kratom.
The authors could not determine whether the change in potassium homeostasis involved the kidneys or another pathway; ongoing research is needed, and one case does not establish that kratom routinely causes hyperkalemia or kidney failure.
Potentially.
FDA testing identified concerning levels of lead and nickel in certain kratom products and warned that prolonged consumption of contaminated products could contribute to kidney damage.
That finding does not establish that every kratom product is contaminated or that heavy metals caused an individual’s kidney condition.
Severe acute kidney injury can lead to lasting kidney dysfunction or chronic kidney disease.
One published case involving kratom-containing supplements and severe multiorgan failure described a patient who remained dependent on dialysis when the report was published.
Other reported patients experienced improved renal function after treatment, so the outcome cannot be predicted from kratom exposure alone.
A high or rising creatinine result may indicate impaired kidney filtration, but it does not identify the cause by itself.
Clinicians consider earlier kidney function results, urine output, other laboratory findings, medications, hydration, and possible medical conditions.
Serum creatinine trends and other findings help determine whether there is an acute injury and what may have contributed to it.
Some people use kratom for pain relief or to manage opioid withdrawal symptoms, but the Food and Drug Administration has not approved kratom for either purpose.
The effects of kratom on renal health remain incompletely understood, and a person’s reason for using it does not establish whether a particular product is safe for their kidneys.
FDA warnings cite safety concerns involving liver toxicity, seizures, substance use disorder, and product contamination, while kidney-specific evidence remains largely limited to clinical reports and contaminant testing.
Severe intoxication can involve complications such as rhabdomyolysis, seizures, prolonged immobility, dehydration, or circulatory problems that may contribute to kidney damage.
Those mechanisms may be relevant even when a direct toxic effect on the kidneys has not been established.
The broader kratom lawsuit investigation covers potential claims involving overdose and other serious injuries.

Tor Hoerman has represented injured individuals for more than 30 years, with experience spanning individual personal injury cases and nationwide mass tort litigation. His work includes car accidents, catastrophic injuries, product liability claims, and other serious injury cases. Tor has served in court-appointed leadership roles in national litigation and tried cases involving major corporate defendants.
TorHoerman Law’s legal content is researched and written by our editorial team and attorneys for legal accuracy, clarity, and relevance. We rely on statutes, court records, government publications, medical research, and other authoritative sources when applicable. This page provides general legal information and does not constitute legal advice.
TorHoerman Law reviews its legal content for factual accuracy, current information, and relevant legal context before publication and as material developments occur. This article is provided for general informational purposes and does not constitute legal advice. For guidance about a specific case, contact TorHoerman Law.
You can learn more about this topic by visiting any of our Kratom Lawsuit pages listed below:
A serious injury can change your life.

TorHoerman Law represents people whose lives have been disrupted by serious injuries, unsafe products, and negligence. Our attorneys handle individual personal injury cases as well as national mass tort lawsuits involving major corporations.
Founded in 2009, our legal team brings more than 100 years of combined experience handling serious injury and complex civil litigation.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!

In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.

In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.

In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.

In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.

In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
A serious injury can change your life.